[podlove-episode-web-player publisher="7239" post_id="7239"]

Blueprint Genetics was founded five years ago as a Stanford University spin-off company. The aim from the beginning has been to bring genetic diagnostics into the daily routines of healthcare organizations. In this podcast Blueprint Genetics’ co-founder Tero-Pekka Alastalo, MD, Ph.D and Lauren Moissiy, MS, LGC, will discuss the origin of the company and what makes Blueprint Genetic a successful genetic testing provider.

Learning objectives:

  • What differentiates Blueprint Genetics form other genetic testing providers
  • What does our unique technology solutions offer
  • How transparency in genetic testing benefits the patient care
  • What is the future of genetic testing in clinical diagnostics





Tero-Pekka Alastalo

Tero-Pekka is the Executive Director of Medical, and also a co-founder at Blueprint Genetics. He is based in San Francisco and holds various responsibilities in the North American operations of the company. Tero-Pekka has an MD-PhD degree and is specialized in pediatrics and pediatric cardiology. He has a PhD in molecular and cellular biology as well. During his 3-year postdoctoral training at Stanford University School of Medicine, he focused on the molecular genetic mechanisms of cardiovascular disease.

Lauren Moissiy

Lauren Moissiy is a trained genetic counselor from San Francisco, CA and is currently the regional sales director for the US with Blueprint Genetics. She has an MS degree in Genetic Counseling from California State University, Stanislaus. Her current focuses are in ophthalmic genetics and genetic causes of sudden unexpected death in the young.

Last modified: 12.10.2018

Subscribe to our podcasts

Subscribe to our newsletter

Subscribe to our newsletter